Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-1-19
pubmed:abstractText
Hypocretins (HCRTs) modulate a variety of behavioral and physiological processes, in part via interactions with multiple ascending modulatory systems. Further, HCRT efferents from the lateral hypothalamus innervate midbrain dopamine (DA) nuclei, and DA cell bodies express HCRT receptors. Combined, these observations suggest that HCRT may influence behavioral state and/or state-dependent processes via modulation of DA neurotransmission. The current studies used in vivo microdialysis in the unanesthetized rat to first characterize the effect of intracerebroventricular infusion of HCRT-1 (0.07, 0.7 nmol) on extracellular levels of DA within the prefrontal cortex (PFC) and nucleus accumbens (Acc). Electroencephalographic/electromyographic measures of sleep-wake state were collected along with select behavioral measures (eg locomotor activity, grooming). HCRT-1 dose-dependently increased PFC dialysate DA levels, and these increases were closely correlated with increases in time spent awake. In contrast, Acc DA levels were unaffected. Additional studies examined whether HCRT-1 acts directly within the ventral tegmental area (VTA) to selectively increase PFC DA efflux and modulate behavioral state. Unilateral infusion of HCRT-1 (0.1, 1.0 nmol) within the VTA increased PFC, but not Acc, DA levels. Importantly, intra-VTA infusion of HCRT-1 increased the time spent awake and grooming. Moreover, HCRT-induced increases in both time spent awake and time spent grooming were significantly correlated with post-infusion PFC DA levels. The current observations predict a prominent modulatory influence of HCRT on PFC-dependent cognitive and affective processes that results, in part, from actions within the VTA. Additionally, these observations suggest that the activation of VTA DA neurons contributes to the behavioral state-modulatory actions of HCRT.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0893-133X
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
384-95
pubmed:dateRevised
2011-5-18
pubmed:meshHeading
pubmed-meshheading:15988471-Analysis of Variance, pubmed-meshheading:15988471-Animals, pubmed-meshheading:15988471-Behavior, Animal, pubmed-meshheading:15988471-Chromatography, High Pressure Liquid, pubmed-meshheading:15988471-Dopamine, pubmed-meshheading:15988471-Dose-Response Relationship, Drug, pubmed-meshheading:15988471-Electroencephalography, pubmed-meshheading:15988471-Electromyography, pubmed-meshheading:15988471-Extracellular Space, pubmed-meshheading:15988471-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:15988471-Male, pubmed-meshheading:15988471-Microdialysis, pubmed-meshheading:15988471-Neuropeptides, pubmed-meshheading:15988471-Nucleus Accumbens, pubmed-meshheading:15988471-Prefrontal Cortex, pubmed-meshheading:15988471-Rats, pubmed-meshheading:15988471-Rats, Sprague-Dawley, pubmed-meshheading:15988471-Ventral Tegmental Area, pubmed-meshheading:15988471-Wakefulness
pubmed:year
2006
pubmed:articleTitle
Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area.
pubmed:affiliation
Department of Psychology, University of Wisconsin, Madison, 53706, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural